umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Benefits of Lactoferrin, Osteopontin and Milk Fat Globule Membranes for Infants
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Paediatrics.
2017 (English)In: Nutrients, ISSN 2072-6643, E-ISSN 2072-6643, Vol. 9, no 8, article id 817Article, review/survey (Refereed) Published
Abstract [en]

The provision of essential and non-essential amino acids for breast-fed infants is the major function of milk proteins. In addition, breast-fed infants might benefit from bioactivities of milk proteins, which are exhibited in the intestine during the digestive phase and by absorption of intact proteins or derived peptides. For lactoferrin, osteopontin and milk fat globule membrane proteins/lipids, which have not until recently been included in substantial amounts in infant formulas, in vitro experiments and animal models provide a convincing base of evidence for bioactivities, which contribute to the protection of the infant from pathogens, improve nutrient absorption, support the development of the immune system and provide components for optimal neurodevelopment. Technologies have become available to obtain these compounds from cow's milk and the bovine compounds also exhibit bioactivities in humans. Randomized clinical trials with experimental infant formulas incorporating lactoferrin, osteopontin, or milk fat globule membranes have already provided some evidence for clinical benefits. This review aims to compare findings from laboratory and animal experiments with outcomes of clinical studies. There is good justification from basic science and there are promising results from clinical studies for beneficial effects of lactoferrin, osteopontin and the milk fat globule membrane complex of proteins and lipids. Further studies should ideally be adequately powered to investigate effects on clinically relevant endpoints in healthy term infants.

Place, publisher, year, edition, pages
MDPI AG , 2017. Vol. 9, no 8, article id 817
Keywords [en]
human milk, bioactive proteins, lactoferrin, osteopontin, milk fat globule membrane
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:umu:diva-139818DOI: 10.3390/nu9080817ISI: 000408688100025OAI: oai:DiVA.org:umu-139818DiVA, id: diva2:1144193
Available from: 2017-09-25 Created: 2017-09-25 Last updated: 2018-06-09Bibliographically approved

Open Access in DiVA

fulltext(1484 kB)140 downloads
File information
File name FULLTEXT01.pdfFile size 1484 kBChecksum SHA-512
a60fcc3e620104c402d31f459b08819fe148ec158de7334c5d02b598733f020f6e9c4144db19c1bbc0d8c52b576bf656f016124dad74ba717286f3be5db39806
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Timby, Niklas

Search in DiVA

By author/editor
Timby, Niklas
By organisation
Paediatrics
In the same journal
Nutrients
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 140 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 234 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf